Literature DB >> 6721883

Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH.

J S Mort, A D Recklies, A R Poole.   

Abstract

The presence of the lysosomal proteinases cathepsin B and cathepsin D at extracellular sites in rheumatoid synovium was demonstrated using the antibody capture technique. Unlike cathepsin D, the cysteine proteinase cathepsin B was commonly detected only at the edges of the synovial explants. Radioimmunoassay and enzyme activity assay of these proteinases demonstrated that both were released from rheumatoid synovial cells in comparable amounts. Since lysosomal cathepsin B is unstable and denatured at physiologic pH and the antibody used only recognizes inactivated enzyme, we believe the selective detection of cathepsin B at the edge of the synovium may be due to the proteinase maintaining a native conformation within the explant, where the pH may be low enough to permit this. By use of a fluorescent substrate in a sensitive, continuous enzyme assay, cathepsin B was shown to express significant activity at neutral and alkaline pH before being inactivated. This and earlier work from this laboratory indicate that cathepsin B secreted by rheumatoid synovial cells may possess extracellular activity in vivo and be involved in the degradation of connective tissue macromolecules.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721883     DOI: 10.1002/art.1780270505

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  33 in total

1.  Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme.

Authors:  L Mach; K Stüwe; A Hagen; C Ballaun; J Glössl
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

Review 2.  Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?

Authors:  Julia S Gelman; Lloyd D Fricker
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

3.  Cathepsin-B-mediated cleavage of Disabled-2 regulates TGF-β-induced autophagy.

Authors:  Yong Jiang; Alec N Woosley; Nageswaran Sivalingam; Sneha Natarajan; Philip H Howe
Journal:  Nat Cell Biol       Date:  2016-07-11       Impact factor: 28.824

4.  Interrelationship of active and latent secreted human cathepsin B precursors.

Authors:  J S Mort; A D Recklies
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

5.  S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.

Authors:  Joanne C Krupa; Sadiq Hasnain; Dorit K Nägler; Robert Ménard; John S Mort
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

6.  An ultrastructural evaluation of the effects of cysteine-proteinase inhibitors on osteoclastic resorptive functions.

Authors:  K Debari; T Sasaki; N Udagawa; B R Rifkin
Journal:  Calcif Tissue Int       Date:  1995-06       Impact factor: 4.333

Review 7.  Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.

Authors:  Klaudia Brix; Joseph McInnes; Alaa Al-Hashimi; Maren Rehders; Tripti Tamhane; Mads H Haugen
Journal:  Protoplasma       Date:  2014-11-16       Impact factor: 3.356

8.  Isolation of a cDNA clone for the human lysosomal proteinase cathepsin B.

Authors:  D Fong; D H Calhoun; W T Hsieh; B Lee; R D Wells
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

9.  Elevation of cathepsin L levels in the synovial lining of rabbits with antigen-induced arthritis.

Authors:  D J Etherington; M A Taylor; B Henderson
Journal:  Br J Exp Pathol       Date:  1988-04

10.  Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions.

Authors:  Silvia Jordans; Sasa Jenko-Kokalj; Nicole M Kühl; Sofia Tedelind; Wolfgang Sendt; Dieter Brömme; Dusan Turk; Klaudia Brix
Journal:  BMC Biochem       Date:  2009-09-22       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.